Bank of New York Mellon’s BIND THERAPEUTICS INC BIND Stock Holding History

Bank of New York Mellon’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16,650	Closed	-$37K	–	4431
2016 Q1	$37K	Buy	16,650 +1	+0%	+$2	﹤0.01%	4116
2015 Q4	$38K	Hold	16,649	–	–	﹤0.01%	4219
2015 Q3	$74K	Hold	16,649	–	–	﹤0.01%	4187
2015 Q2	$93K	Buy	16,649 +3,962	+31%	+$24.6K	﹤0.01%	4062
2015 Q1	$70K	Buy	+12,687	New	+$78K	﹤0.01%	4108
2014 Q2	–	Sell	-21,525	Closed	-$258K	–	4342
2014 Q1	$258K	Buy	+21,525	New	+$281K	﹤0.01%	3780

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bank of New York Mellon's BIND Position: Q2 2016 in Review

Bank of New York Mellon sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 16,650 shares — an estimated $37K sold.

Bank of New York Mellon first reported a position in BIND in Q1 2014 and held it in 6 quarters. The position peaked at $258K in Q1 2014. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

Bank of New York Mellon reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
Bank of New York Mellon sold 16,650 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $37K.
Bank of New York Mellon first reported a position in BIND THERAPEUTICS INC in Q1 2014 and held it in 6 quarters.
Bank of New York Mellon's BIND THERAPEUTICS INC position peaked at $258K in Q1 2014.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Bank of New York Mellon's 13F filing for Q2 2016, filed 1 Aug 2016.